Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2023 08:01 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces First Quarter 2023 Financial Results

Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4...
April 18, 2023 17:10 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System

HOLLISTON, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the initial order for the Company’s new high-capacity behavioral...
April 17, 2023 16:45 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET

HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April...
March 16, 2023 17:14 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023

HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
March 16, 2023 09:25 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023

HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
March 09, 2023 07:00 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Fourth Quarter 2022 Financial Results

HOLLISTON, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31,...
February 28, 2023 16:10 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET

HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on...
December 12, 2022 08:30 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces CFO Transition

HOLLISTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer...
November 08, 2022 16:01 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Announces Third Quarter 2022 Financial Results

HOLLISTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Jim...
November 02, 2022 17:15 ET | Source: Harvard Bioscience, Inc.

Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET

HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2022 after the market closes on...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right